EL

Estée Lauder EL · NYSE

$105.80 +1.21% (+$1.26)

Summary

23 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 8.7 USD is left as free cash.
  • It beat profit estimates 7 times in the last 8 quarters.

What to watch

  • Earnings per share fell by 44% a year over the last 3 years.
  • Repaying its net debt would take 5.7 years of operating profit.
  • It pays out more in dividends than it earns: 279% of profit.
  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $105.8
5-year average P/E 91.5 127% higher
P/E today 208.1
Household & Personal Products industry median
P/E today 208.1

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 208.1 USD for 1 USD of yearly profit. Over the last five years it was 91.5 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue fell by 1.5% a year over 5 years. Over the last 3 years it fell by 1.8% a year. For the next fiscal year analysts expect revenue to grow by 4.6%. Earnings per share fell by 44% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 USD of revenue goes

Net profit, industry median (Household & Personal Products) 9.0 USD

Out of every 100 USD of revenue, 1.2 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 7.0 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, at risk
Yield
1.34%
Paid out of profit
279%

You receive $1.40 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $103 is 2.6% below today's price. 48% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2026

By product

By region

Skin Care brings in 49% of revenue. Fragrance grew fastest, by 2.6% a year.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.